Acta Med. 2011, 54: 51-57

https://doi.org/10.14712/18059694.2016.18

B Cell Toll-like Receptors with Respect to the Pathogenesis of Sjögren’s Syndrome

Irena Berglováa,b, Jan Krejseka, Martina Koláčkováa, Radovan Slezákb

aCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Department of Clinical Immunology and Allergology, Czech Republic
bCharles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Department of Dentistry, Czech Republic

Received November 22, 2010
Accepted February 21, 2011

References

1. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of doublestranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001 Oct 18;413(6857):732–8. <https://doi.org/10.1038/35099560>
2. Ballas ZK, Krieg AM, Warren T et al. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol 2001; 67(9):4878–86. <https://doi.org/10.4049/jimmunol.167.9.4878>
3. Bernasconi NL, Onai N, Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood. 2003 Jun 1;101(11):4500–4. <https://doi.org/10.1182/blood-2002-11-3569>
4. Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 2003 Aug 1;102(3): 956–63. <https://doi.org/10.1182/blood-2002-11-3355>
5. Boule MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin- immunoglobulin G complexes. J. Exp. Med. 2004 June 21; 199(12): 1631–1640. <https://doi.org/10.1084/jem.20031942> <PubMed>
6. Carsons S, Harris EK et al. The new Sjogren’s syndrome handbook. 1998; 3–10,71–85.
7. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004 Mar 5;303(5663):1529–31. <https://doi.org/10.1126/science.1093616>
8. Duddy M, Niino M, Adatia F, et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 2007;178:6092–6099. <https://doi.org/10.4049/jimmunol.178.10.6092>
9. Fox RI, Pearson G, Vaughan JH. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjőgren’s syndrome. J Immunol 1986;137:3162–8.
10. Gao B, Tsan MF. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor a release by murine macrophages. J. Biol. Chem 2003;278:174. <https://doi.org/10.1074/jbc.M208742200>
11. Gorden KB, Gorski KS, Gibson SJ, et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol. 2005;174: 1259–1268. <https://doi.org/10.4049/jimmunol.174.3.1259>
12. Hanten JA, Vasilakos JP, Riter CL, Neys L, Lipson KE, Alkan SS, Birmachu W. Comparison of human B cell activation by TLR7 and TLR9 agonists. BMC Immunol 2008;9:39. <https://doi.org/10.1186/1471-2172-9-39> <PubMed>
13. Heil F, Hemmi H, Hochrein H, et. al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004 Mar 5;303(5663):1526–9. <https://doi.org/10.1126/science.1093620>
14. Hemmi H, Kaisho T, Takeuchi O, et. al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002 Feb;3(2):196–200. <https://doi.org/10.1038/ni758>
15. Horng T, Barton GM, Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2001 Sep;2(9
16. Iványi D, Dřízhal I, Erbenová E, et al. HL-A in Sjögren’s syndrome. Tissue Antigens. 1976 Jan;7(1):45–51. <https://doi.org/10.1111/j.1399-0039.1976.tb01028.x>
17. Jiang Z, Mak TW, Sen G, Li X. Toll-like receptor 3-mediated activation of NFkappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3533–8. <https://doi.org/10.1073/pnas.0308496101> <PubMed>
18. Jonsson R, Bowman S, Gordon T. Sjőgren‘s syndrome. In: Koopman W, Moreland L, eds. Arthritis and Allied Conditions – A Text- book of Rheumatology. Philadelphia, USA: Lippincott Williams and Wilkins, 2005:1681–705.
19. Jonsson R, Bolstad AI, Brokstad KA, Brun JG. Sjögren’s syndrome—a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci. 2007 Jun;1108:433–47. <https://doi.org/10.1196/annals.1422.046>
20. Kalfus P, Dřízhal I, Živný P. Orální lichen planus a hepatitida C. LKS č.2. 2006 Feb;16:18–21.
21. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88- deficient mice to endotoxin. Imunity 1999 Jul;11(1):115–22. <https://doi.org/10.1016/S1074-7613(00)80086-2>
22. Kawai T, Takeuchi O, Fujita T, et al. Lipopolysaccharide stimulates the MyD88- independent pathway and results in activation of IRF-3 and the expression of a subset of LPS-inducible genes. J. Immunol 2001 Nov 15;167(10):5887–94. <https://doi.org/10.4049/jimmunol.167.10.5887>
23. Kawakami A, Nakashima K, Tamai M, et al. Toll-like receptor in salivary glands from patients with Sjögren’s syndrome: functional analysis by human salivary gland cell line. J Rheumatol. 2007 May;34(5):1019–26.
24. Kim WU, Sreih A, Bucala R. Toll-like receptors in systemic lupus erythematosus; prospects for therapeutic intervention. Autoimmun Rev. 2009 Jan;8(3):204–8. <https://doi.org/10.1016/j.autrev.2008.07.046> <PubMed>
25. Krug A, Rothenfusser S, Hornung V, et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 2001;31(7):2154–63. <https://doi.org/10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U>
26. Lanzavecchia A, Sallusto F. Toll-like receptors and innate immunity in B-cell activation and antibody responses. Curr Opin Immunol. 2007 Jun;19(3):268–74. <https://doi.org/10.1016/j.coi.2007.04.002>
27. Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA et al: RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005. 202: 1171–7. <https://doi.org/10.1084/jem.20050630> <PubMed>
28. Leadbetter A, Rifkin IR, Hohlbaum AM Beaudette BC, Shlomchik MJ, Marshak- Rothstein A: Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002 416: 603–7. <https://doi.org/10.1038/416603a>
29. Lund FE. Cytokine-producing B lymphocytes – key regulators of immunity. Curr Opin Immunol 2008 June, 20(3):332–338. <https://doi.org/10.1016/j.coi.2008.03.003> <PubMed>
30. Maaser C, Heidemann J, von Eiff C. Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin. J. Immunol 2004;172:5056. <https://doi.org/10.4049/jimmunol.172.8.5056>
31. Manicassamy S, Pulendran B. Modulation of adaptive immunity with Toll-like receptors. Seminars in Immunology. 2009 Aug;21(4):185–193. <https://doi.org/10.1016/j.smim.2009.05.005> <PubMed>
32. Manoussakis MN, Spachidou MP, Maratheftis CI. Salivary epithelial cells from Sjogren’s syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. J Autoimmun. 2010 Nov;35(3):212–8. <https://doi.org/10.1016/j.jaut.2010.06.010>
33. Mariette X, Gottenberg J-E. Pathogenesis of Sjogren’s syndrome and therapeutic consequences. September 2010 Sept;22(5)471–477.
34. Mariette X, Agbalika F, Zucker-Franklin D, et al. Detection of the tax gene of HTVL-I in labial salivary glands from patients with Sjőgren’s syndrome and other diseases of the oral cavity. Clin Exp Rheumatol 2000;18:341–7.
35. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nature Rev Immunol 2006. 6: 823–35. <https://doi.org/10.1038/nri1957> <PubMed>
36. Meyer-Bahlburg A, Rawlings DJ. B cell autonomous TLR signalling and autoimmunity. Autoimmun Rev. 2008 Feb;7(4):313–6. <https://doi.org/10.1016/j.autrev.2007.11.027> <PubMed>
37. Nikolov NP, Illei GG. Pathogenesis of Sjőgren‘s syndrome. Curr Opin Rheumatol. 2009 Sept;21(5):465–470. <https://doi.org/10.1097/BOR.0b013e32832eba21> <PubMed>
38. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem. 2003 Dec 12;278(50): 49751–62. <https://doi.org/10.1074/jbc.M305820200>
39. Palanichamy A, Barnard J, Zheng B, et al. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol. 2009 May 15;182(10): 5982–93. <https://doi.org/10.4049/jimmunol.0801859> <PubMed>
40. Pariente D, Anaya JM, Combe B, et. al. Non-Hodgkin’s lymphoma associated with primary Sjögren’s syndrome. Eur J Med. 1992 Oct;1(6):337–42.
41. Pirisi M, Scott C, Fabris C et al. Mild sialoadenitis: a common finding in patients with hepatitis C virus infection. Scand J Gastroenterol 1994 Oct;29(10):940–2. <https://doi.org/10.3109/00365529409094867>
42. Ramos-Casals M, Mu, Zern PB. Hepatitis C virus and Sjögren’s syndrome: trigger or mimic? Rheum Dis Clin North Am. 2008 Nov;34(4):869–84, vii. <https://doi.org/10.1016/j.rdc.2008.08.007>
43. Reveille JD, Arnett FC. The immunogenetics of Sjogren’s syndrome. Rheum Dis Clin North Am. Aug 1992;18(3):539–50.
44. Ruprecht CR, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol. 2006 Apr;36(4): 810–6. <https://doi.org/10.1002/eji.200535744>
45. Sanz I, Anolik JH, Looney RJ. B cell depletion therapy in autoimmune diseases. Front Biosci 2007;12:2546–2567. <https://doi.org/10.2741/2254>
46. Shlomchik MJ. Activating systemic autoimmunity: B’s, T’s, and tolls. Curr Opin Immunol 2009 Dec;21(6):626–33. <https://doi.org/10.1016/j.coi.2009.08.005> <PubMed>
47. Steinfeld SD, Doels P, Van Vooren JP, Cogan E, Appelboom T. Zidovudin in primary Sjőgren’s syndrome. Rheumatology 1999;38:814–7. <https://doi.org/10.1093/rheumatology/38.9.814>
48. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003; 21:335–76. <https://doi.org/10.1146/annurev.immunol.21.120601.141126>
49. Takeda K, Akira S. Toll-like receptors in innate immunity. Int. Immunol 2005; 17:1–14. <https://doi.org/10.1093/intimm/dxh186>
50. Takeuchi O, Kawai T, Mühlradt PF, et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 2001 Jul;13(7):933–40. <https://doi.org/10.1093/intimm/13.7.933>
51. Takeuchi O, Sato S, Horiuchi T, et al. Cutting edge: role of TLR1 in mediating immune response to microbial lipoproteins. J. Immunol. 2002 Jul 1;169(1):10–4. <https://doi.org/10.4049/jimmunol.169.1.10>
52. Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira, S. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int. Immunol 2000 Jan;12(1):113–7. <https://doi.org/10.1093/intimm/12.1.113>
53. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003 Dec; 19(6):837–47. <https://doi.org/10.1016/S1074-7613(03)00323-6>
54. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003;19(6): 837–847. <https://doi.org/10.1016/S1074-7613(03)00323-6>
55. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjőgren‘s syndrome: a revised version of the European criteria proposed by the American- European Consensus Group. Ann Rheum Dis 2002;61:554–8. <https://doi.org/10.1136/ard.61.6.554> <PubMed>
56. Yamamoto M, Sato S, Hemmi H, et al. Essential role of TIRAP/Mal for activation of the signaling cascade shared by TLR2 and TLR4. Nature 2002;420: 324–329. <https://doi.org/10.1038/nature01182>
57. Yamamoto M, Sato S, Hemmi H, et al. Essential role of TIRAP/Mal for activation of the signaling cascade shared by TLR2 and TLR4. Nature 2002; 420:324–329. <https://doi.org/10.1038/nature01182>
58. Zheng L, Zhang Z, Yu C, Yang C. Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 Jun;109(6):844–50. <https://doi.org/10.1016/j.tripleo.2010.01.006>
59. Zheng L, Yu C, Zhang Z, Yang C, Cai X. Expression of interferon regulatory factor 1, 3, and 7 in primary Sjögren syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009 May;107(5):661–8. <https://doi.org/10.1016/j.tripleo.2009.01.039>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive